Thus, a study demonstrated MIRA-1’s capability of inducing p53-mediated apoptosis in different tumor cells in which each had borne a discrete mutation (R175H, R248Q, and R273H) in their p53 gene [706]. The gene discussed is TP53; the disease is neoplasm.